Immunophenotyping of CAR T cell activation using flow cytometry
MBTP 53 = Miltenyi Biotec-tested panel 53
This application protocol describes the analysis of chimeric antigen receptor (CAR) T cell activation. To demonstrate the state-of-the-art panel, CAR T cells were generated within 12 days using the CliniMACS Prodigy® T Cell Transduction process. CAR T cell activation was analyzed using Miltenyi Biotec’s automated data acquisition and analysis Express Mode program “CAR T Cell Express Mode Package”.
- Volumes given below are for up to 106 nucleated cells. When working with fewer than 106 cells, use the same volumes as indicated. When working with higher cell numbers, scale up all reagent volumes and total volumes accordingly (e.g., for 2 × 106 nucleated cells, use twice the volume of all indicated reagent volumes and total volumes).
- Cell number was determined.
- Cells were centrifuged at 300 × g for 10 minutes. Supernatant was aspirated completely.
- Up to 106 nucleated cells were resuspended in 100 µL of PEB buffer.
- CD19 CAR Detection Reagent, human, Biotin was added according to the dilution mentioned in the respective data sheet.
▲Note: Alternative CAR Detection Reagents can be used. - Cells were resuspended and incubated for 10 minutes in the dark at room temperature (+19 to +25 °C).
- Cells were washed by addition of 1 mL of PEB buffer and centrifuged at 300 × g for 5 minutes. Supernatant was aspirated completely. Repeat washing step once.
- A staining cocktail with all antibodies and 7-AAD was prepared according to the dilutions mentioned in the respective data sheets.
- 100 µL staining cocktail was added to the cells.
- Cells were resuspended and incubated for 10 minutes in the dark at room temperature (+19 to +25 °C).
- Cells were washed by addition of 1 mL of PEB buffer and centrifuged at 300 × g for 5 minutes. Supernatant was aspirated completely.
- Cells were resuspended in 500 µL of PEB buffer. 5 µL of 7-AAD Staining Solution was added and incubated for 5 minutes in the dark at room temperature right before flow cytometric analysis using the MACSQuant® Analyzer 10.
Antibody panel for CAR T cell activation
| Specificity | Clone | Purpose | Fluorochrome | Detection filter (nm) (laser) |
| 7-AAD* | - | Viability | - | 655-730 (blue) |
| CD3 | REA613 | T cells | FITC | 525/50 (blue) |
| CD4 | REA623 | Helper T cells | VioGreen™ | 525/50 (violet) |
| CD8 | REA734 | Cytotoxic T cells | APC-Vio® 770 | 750 LP (red) |
| CD137 | REA765 | T cell activation | APC | 655−730 (red) |
| CD154 | REA238 | T cell activation | VioBlue® | 450/50 (violet) |
| CD25 | REA570 | T cell activation | PE-Vio 770 | 750 LP (blue) |
| CD19 CAR Detection Reagent, Biotin** | - | CAR+ cells | - | - |
| Biotin | REA746 | CAR+ cells | PE | 585/40 (blue) |
*Alternative CE-IVD/ASR reagent for 7-AAD available (# 170-100-042).
** Alternative CAR Detection Reagents can be used. Choose a CAR Detection Reagent detectable in the PE channel, e.g., CD19 CAR Detection Reagent, human, Biotin (# 130-129-550), CD22 CAR Detection Reagent, human, Biotin (# 130-126-727), BCMA CAR Detection Reagent, human, Biotin (# 130-126-090), CD33 CAR Detection Reagent, human, Biotin (# 130-127-642), CD19 CAR FMC63 Idiotype Antibody, PE, REAfinity™ (# 130-127-342), or CD19 CAR FMC63 Idiotype Antibody, Biotin, REAfinity (# 130-127-345 or # 130-127-349).
Gating strategy
9 products found
|
For research use only
For research use only
FC
100 tests in 200 µL
(excl. tax)
For research use only
1 mL
(excl. tax)
For research use only
For research use only
FC, MICS, IF, IHC
100 tests in 200 µL
(excl. tax)
For research use only
For research use only
FC
100 tests in 200 µL
(excl. tax)
For research use only
For research use only
FC, MICS, IF, IHC
100 tests in 200 µL
(excl. tax)
For research use only
For research use only
FC
100 tests in 200 µL
(excl. tax)
For research use only
For research use only
ICFC
30 tests in 60 µL
(excl. tax)
For research use only
For research use only
FC
100 tests in 200 µL
(excl. tax)
For research use only
For research use only
FC
30 tests in 60 µL
(excl. tax)
You have previously chosen International as your location.
What do you want to do?